Pitavastatin Calcium is a competitive inhibitor of the enzyme HMGCR (HMG-CoA reductase) results in a reduction in LDL cholesterol synthesis. Alternate studies show that pitavastatin can suppress oxygen production in endothelial cells by inhibiting Nox (NADPH oxidase). In addition, pitavastatin reduces the expression of eNOS mRNA while increasing the NO dependent response stimulated by acetylcholine and the calcium ionophore, A23187 (sc-3591). Furthermore, pitavastatin inhibits the up-regulation of conductance calcium-activated potassium channels by lowering cholesterol levels in cells.
1. Kajinami, K., et al. 2003. Cardiovasc Drug Rev. 21: 199-215. PMID: 12931254
2. Terata, Y., et al. 2003. Pharmacology. 68: 169-176. PMID: 12837970
3. Hayashi, T., et al. 2004. Atherosclerosis. 176: 255-263. PMID: 15380447
4. Takayama, T., et al. 2004. Circ. J. 68: 1067-1075. PMID: 15502390
看其他用户如何应用Pitavastatin Calcium (CAS 147526-32-7).点击进入浏览PubMed条目 .
PMID: # 25993292 Yoshimura, K. et al. 2015. Int J Mol Sci. 16: 11213-28.
PMID: # 24671957 Chang, JH. et al. 2014. Drug Metab. Dispos. 42: 1067-73.
PMID: # 23750830 Chang, JH. et al. 2013. Mol. Pharm. 10: 3067-75.
PMID: # 23564645 Zhang, X. et al. 2013. Toxicological sciences : an official journal of the Society of Toxicology. 134: 73-82.
PMID: # 31772607 Cardiovasc Ther. 2019: 2549432.
PMID: # 31527323 J. Atheroscler. Thromb. 27: 429-440.
PMID: # 32435188 Front Pharmacol. 469.
圣克鲁斯生物技术在生物医药研究市场的产品开发方面处于世界领先地位。欢迎 致电我们的免费电话(021) 800-820-8626。 版权 ©, 2007-2021圣克鲁斯生物技术。版权所有。“Santa Cruz Biotechnology”,圣克鲁斯生物技 术的 商标,“Santa Cruz Animal Health”,“San Juan Ranch”,“Supplement of Champions”,San Juan Ranch的商标,“Ultracruz”,“Chemcruz”,“Immunocruz”,“Exactacruz”和“EZ Touch”都是圣克鲁斯生物技术的注册商标。所有的商标都归其各自拥有者所有。